Sacubitril/Valsartan: Beyond Natriuretic Peptides

Heart - United Kingdom
doi 10.1136/heartjnl-2017-311295
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Potential Markers of Sacubitril-Valsartan Tolerance

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Sacubitril/Valsartan Use for the Hospitalist

American Journal of Hospital Medicine
2017English

Sacubitril/Valsartan Verbessern Auch Den HbA1c-Wert

MMW Fortschritte der Medizin
Medicine
2017English

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Reply: Sacubitril/Valsartan for Chagas' Heart Disease Heart Failure?

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Perceived Barriers to Sacubitril/Valsartan Use in Patients With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Effects of Very Low (12/13mg) and Low Dose (24/26mg) Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Pcv6 - Sacubitril/Valsartan in Heart Failure: Projected Health Outcomes in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Sacubitril-Valsartan Initiation Post-Left Ventricular Assist Device Is Safe and Effective

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy